Last fact-check: August 9, 2026.

Independent review for U.S. optometry practices and existing Uprise users. TradeTech Guide is not VisionWeb, HELIX, EssilorLuxottica, an eye-care practice, or a patient portal. We did not receive a vendor payment, product access, a private demonstration, or a contract for this review. Product availability, clinical configuration, prices, integrations, security terms, and support obligations must be confirmed in writing with the vendor.

Quick Answer

Uprise is a real optometry practice-management and electronic health record product with an active staff login, an active learning center, public FHIR documentation, and current official certification materials. That evidence is stronger than an old marketing page or a software-directory profile.

The complicated part is its buying status. VisionWeb's former Uprise product URL now redirects visitors toward HELIX and Vision(X). HELIX presents Vision(X) as its next-generation practice-management and EHR suite, but the current Vision(X) FAQ says that product is not available yet. Meanwhile, an official VisionWeb-hosted Uprise page still invites practices to request a Uprise demonstration and lists Uprise packages without dependable public prices.

That combination does not prove Uprise is discontinued, nor does it prove every new prospect can buy the same Uprise version used by existing customers. It means a buyer should ask one question before investing time in a demonstration:

Is this quote and implementation for Uprise 3.1, for a future Vision(X) product, or for a migration path involving both?

Get the answer in the order form, along with product-lifecycle dates, upgrade rights, migration responsibilities, data-export rights, and support commitments.

For an existing practice user, the official application entry point is youruprise.com, which redirects to VisionWeb's authentication service. For training, use the Uprise Learning Center. Patients should follow the portal link and instructions issued by their own eye-care practice; the staff login is not a universal patient login.

Uprise Status in 2026: Active Product, Unclear New-Buyer Path

Several current signals show that Uprise remains operational:

  • the official youruprise.com entry point redirects to a live VisionWeb authorization flow;
  • the Uprise Learning Center has a current login, password reset, two-factor authentication flow, and public course catalog;
  • the Uprise SMART on FHIR server and documentation are reachable;
  • HELIX continues to publish a Uprise 3.1 Costs & Considerations page and real-world testing files;
  • the 2024 real-world testing report describes Uprise use in live production; and
  • a February 2025 VisionWeb article discussed Uprise and the forthcoming Vision(X) as separate EHRs.

The public sales path is less consistent. The old visionweb.com/uprise destination no longer functions as the primary Uprise product page. VisionWeb visitors are routed into the current HELIX portfolio, where the public PMS/EHR product is Vision(X). The current Vision(X) page says the new product is not yet available and offers a form for future information. At the same time, the official Uprise demo page remains online, carries a 2026 copyright notice, describes Uprise features and packages, and accepts demonstration requests.

The responsible conclusion is therefore limited: Uprise appears active for installed users, but its current new-customer availability and long-term position beside Vision(X) need written confirmation. We did not find a current public end-of-sale date, end-of-support date, forced-migration date, or release date for Vision(X).

Questions that resolve the status ambiguity

Send these questions before scheduling a long discovery call:

  1. Are you accepting new Uprise customers today?
  2. What exact product name, version, hosting service, and legal entity will appear on the order form?
  3. Is Uprise 3.1 the production version a new customer will receive?
  4. Is Vision(X) a replacement, an optional successor, or a separate offering?
  5. What are the contractual end-of-sale, end-of-maintenance, and end-of-support dates for Uprise?
  6. Will a new Uprise customer receive Vision(X), and if so, is migration mandatory or optional?
  7. Which configuration, data, attachments, templates, interfaces, audit history, and financial records will transfer?
  8. Who pays for migration, validation, retraining, interface changes, parallel operation, and downtime?
  9. Can the practice decline migration and remain supported on Uprise for the original contract term?
  10. What happens if Vision(X) is delayed or fails the practice's acceptance tests?

Verbal reassurance is useful for discovery, but lifecycle commitments belong in the signed documents.

Who Owns Uprise and VisionWeb?

The current HELIX About page describes HELIX as a division of EssilorLuxottica and says the portfolio brings together U.S. digital solutions including VisionWeb, CLX, 4PatientCare, and Revenue Cycle Management. HELIX's January 8, 2026 website terms identify VisionWeb Holdings, LLC, also known as HELIX, as a subsidiary of Essilor of America Inc.

That corporate structure helps explain why older VisionWeb pages, youruprise.com applications, HELIX pages, and EssilorLuxottica references can all appear during one buying journey. It does not establish which entity signs a specific Uprise customer agreement. Confirm the contracting party, service provider, payment recipient, business associate, data custodian, support organization, and notice address in the documents you will actually sign.

Do not confuse the current VisionWeb product page with Uprise. On the HELIX site, “VisionWeb” is now presented primarily as an online optical-ordering solution. Uprise is the PM/EHR evaluated here. Vision(X) is the forthcoming HELIX PM/EHR described on the current site. Similar branding does not make the products interchangeable.

Uprise Login, Learning Center, and Patient Portal

Branded searches such as “youruprise” and “Uprise login” often come from existing users rather than software buyers. Use the correct route for the correct role.

Staff application login

Practice users should start at www.youruprise.com. It currently redirects into auth.visionweb.com with an authorization request for the Uprise application. Bookmark the official domain, not a third-party login directory or a copied authorization URL. Authorization URLs contain changing state and nonce values and should not be shared as permanent links.

If access fails:

  1. confirm the user started from the official domain;
  2. check whether the problem affects one user, one browser, one location, or the whole practice;
  3. ask the practice administrator to verify the user's status and role;
  4. use the official password-recovery route rather than sending credentials by email;
  5. preserve the exact time, error message, browser, location, and affected workflow; and
  6. contact vendor support through the practice's approved channel.

Never place patient information, credentials, screenshots containing protected health information, or access tokens in an ordinary support email unless the vendor has provided an approved secure method.

Training login

The Uprise Learning Center is a separate training service. Its current sign-in flow supports password recovery and shows multiple two-factor authentication paths, including an authenticator code, backup code, and secure email sign-in link. A working learning-center password does not necessarily grant production Uprise access, and production credentials should not be tested on unrelated sites.

The public course catalog is useful evidence of product scope. It contains courses for managing patient information, patient portal setup, scheduling, EHR foundations, pre-test work, e-prescribing, physical exams, refraction, finishing an exam, and billing or coding work. It also groups material under Front Desk, Practice Management, EHR, and technician categories.

Course titles prove that training content exists; they do not prove a function is enabled in every package, configured for every practice, current for every production screen, or included without a third-party dependency. During implementation, map each required role to a current course, a configured workflow, supervised practice, and a passed competency test.

Patient portal access

The learning catalog says staff learn how to set up a patient portal account and help patients access visit information, educational materials, office communications, and pre-visit questionnaires. VisionWeb's 2025 Eyeglass Rule article also refers to Uprise's associated patient portal.

Patients should use the invitation, link, practice identifier, and support instructions supplied by their own eye-care provider. The Uprise staff login is not a patient portal, and a generic portal-looking page may require practice-specific context. A patient with an access or record question should contact the treating practice first. TradeTech Guide cannot access accounts or medical records.

Practices should test portal enrollment, identity verification, proxy access, consent, password recovery, prescription delivery, message routing, document availability, retention, and audit evidence with counsel and compliance staff. A portal can support a workflow; it does not make the practice compliant by itself.

What Uprise Can Be Verified to Cover

Uprise is presented by the official demo page as a cloud-based PM/EHR for eye-care practices. The page identifies EHR and practice management, e-prescribing, secure messaging, training and support, lab ordering, patient portal, patient recall or reminders, optical content, and optional revenue-cycle services across named packages.

The current learning catalog independently supports the existence of several workflow areas:

  • patient creation and demographic information;
  • scheduling and appointment editing;
  • patient portal setup and use;
  • EHR charting foundations;
  • pre-test information, vital signs, and questionnaires;
  • e-prescribing workflows;
  • physical and refraction exam documentation;
  • spectacle and contact-lens work within exam training; and
  • billing and coding steps when finishing an exam.

Official certification materials add evidence for a defined set of clinical and interoperability capabilities. They do not verify every marketing claim or every operational module.

Demonstrate workflows, not feature nouns

A buyer should bring scripted scenarios to the demonstration:

  1. register a new patient and detect a possible duplicate;
  2. schedule, reschedule, cancel, and document a no-show;
  3. complete a representative comprehensive eye exam and a problem-focused visit;
  4. handle allergies, medications, prescriptions, diagnoses, orders, results, and amendments;
  5. create spectacle and contact-lens documentation with the practice's real edge cases;
  6. move from clinical documentation to charges without silently duplicating codes;
  7. submit, reject, correct, remit, post, refund, and reconcile a test claim or payment workflow;
  8. enroll a test patient in the portal and recover access;
  9. send and receive a representative clinical document;
  10. run the exact daily, month-end, provider, payer, inventory, and audit reports the practice uses;
  11. export one patient's complete record and a representative population dataset; and
  12. revoke a user, review the audit trail, and investigate a deliberately failed transaction.

Use de-identified or vendor-provided test data. Clinical, coding, billing, privacy, and financial owners should approve the configured results rather than relying on a sales walkthrough.

Uprise Pricing in 2026

We did not find a dependable public Uprise subscription price. The current official demo page lists four package names—Uprise Essentials, Uprise Essentials + RCM, Uprise Pro, and Uprise Pro + RCM—but its price cells say to contact the company for a quote and contain stray numbers that are not credible subscription prices. They should not be reconstructed into a price table.

Older VisionWeb FAQ content describes a conversion fee, implementation fee, and recurring per-doctor fee. Because that page belongs to the older VisionWeb site structure and does not establish an effective date or current order terms, treat it as historical context, not a 2026 quote.

HELIX's Uprise Costs & Considerations page says there are no additional one-time or ongoing costs to use the certified product. That statement appears in an ONC certification disclosure. It should not be read as saying the entire Uprise subscription, implementation, prescribing service, messaging, clearinghouse, RCM, migration, hardware, or every integration is free.

Request a three-year total-cost schedule

Ask the vendor to price each category and identify the billing unit:

  • base PM/EHR subscription by provider, location, user, record volume, or other unit;
  • Essentials, Pro, and any successor or Vision(X) rights;
  • implementation, project management, workflow design, configuration, and go-live support;
  • source extraction, cleanup, conversion, rehearsals, validation, and remediation;
  • e-prescribing, controlled-substance functionality, identity proofing, and third-party licenses;
  • claims, eligibility, remittance, clearinghouse, statement, payment, and RCM services;
  • portal, forms, recall, messaging, phone, email, and usage overages;
  • optical ordering, Frames Data, labs, inventory, code verification, patient education, and other embedded services;
  • diagnostic device, imaging, lab, payer, API, FHIR, and custom interfaces;
  • training for new hires and refresher training after launch;
  • storage, archived data, attachments, images, exports, and retention;
  • support tiers, after-hours help, professional services, and custom reporting;
  • browser devices, scanners, printers, label workflows, privacy accessories, network changes, backup connectivity, and local IT;
  • renewal increases, minimum commitments, taxes, and payment terms; and
  • termination, data export, migration assistance, read-only access, retention, and deletion.

Request sample invoices for implementation, an ordinary month, a high-volume month, an added-provider month, a support project, renewal, and termination. A total without billing triggers is not a usable comparison.

ONC Certification and Real-World Testing

The HELIX disclosure identifies VisionWeb Uprise version 3.1 with certification ID 15.04.04.2514.Upri.31.01.1.221213, certified December 13, 2022. It lists certified criteria, clinical quality measures, and relied-upon software including NewCropRx, Secure Exchange Solutions, and Dynamic Health IT components.

This is meaningful evidence that a defined Uprise module was tested against defined certification criteria. The page also states that certification is not an endorsement by the U.S. Department of Health and Human Services. Certification does not prove that every Uprise package contains every capability, that a practice is automatically compliant, that uptime is guaranteed, that all interfaces are bidirectional, or that every workflow is error-free.

The official 2024 Uprise real-world testing results say VisionWeb evaluated Uprise 3.1 in ambulatory eye care using production audit data over 90-day periods and interactive testing with ten internal participants. The report says the observed certification and interoperability tasks completed their expected outcomes. It also records limitations: one e-prescribing acceptance metric could not be captured because of available system data and a NewCrop dependency, and participants were unfamiliar with several low-use workflows.

The report further says VisionWeb had not updated Uprise to new standards through the Standards Version Advancement Process or Cures Update criteria before executing the 2024 test. That is not the same as decertification. It is a reason to ask which standards, USCDI version, certification listing, API implementation, and regulatory updates apply to the production version being quoted in 2026.

Verify the current CHPL listing and certification status immediately before purchase. Include a contract remedy if a required certification or capability changes during the term.

FHIR API: Useful Certified Scope, Not a General Integration Promise

The current Uprise SMART on FHIR documentation describes OAuth 2.0 and SMART authorization, client registration, patient-scoped access, bulk export, and mappings between U.S. Core Data for Interoperability categories and FHIR resources.

The documentation states that the API allows other health IT applications to make read-only requests for patient health information within USCDI scope. It includes resources such as Patient, Condition, Observation, Goal, Immunization, AllergyIntolerance, DocumentReference, Practitioner, Encounter, and Organization, with documented search patterns. It also describes system-level read scope for bulk export.

That is valuable, but it should not be expanded into “Uprise has an open API for everything.” The public documentation does not establish a supported write API for scheduling, inventory, accounting, claims, optical orders, custom fields, or every operational object. It also does not establish pricing, production registration time, service levels, rate limits, data latency, tenant-specific availability, change notice, or support ownership for a buyer's proposed integration.

For each integration, require a written interface sheet covering:

  • exact source and destination products, versions, and tenant;
  • FHIR resource, proprietary API, file, database, browser automation, or manual workflow;
  • read versus write direction and field-level scope;
  • patient matching, duplicate handling, corrections, deletes, and provenance;
  • authentication, authorization, token rotation, least privilege, and audit logging;
  • data freshness, rate limits, retry behavior, downtime, and error notification;
  • sandbox availability and representative test data;
  • vendor, partner, and practice support responsibilities;
  • one-time and recurring charges;
  • acceptance tests and production monitoring; and
  • export and termination behavior.

A SMART on FHIR endpoint can satisfy a patient-access or certified interoperability use case while remaining insufficient for a practice's operational integration.

Optical Ordering, Devices, and Third-Party Dependencies

The Uprise demo page describes VisionWeb optical ordering within the product, and HELIX still publishes a VisionWeb ordering platform. The Uprise Costs & Considerations disclosure identifies multiple relied-upon software products for certified functions. These dependencies can reduce duplicate work when correctly configured, but they also divide support and contract responsibility.

For every lab, frame catalog, contact-lens source, diagnostic instrument, prescribing service, payer, clearinghouse, payment service, messaging service, or patient-engagement tool, verify:

  • exact product and model compatibility;
  • whether the connection is native, embedded, file-based, browser-based, or operated by a third party;
  • which fields and documents move in each direction;
  • required local drivers, bridges, ports, folders, workstations, or browser settings;
  • the source of truth when two systems disagree;
  • failure, retry, duplicate, correction, and reconciliation procedures;
  • support escalation and maintenance ownership;
  • security review and business-associate coverage where applicable;
  • fees, volume limits, and contract terms; and
  • what continues to work after either vendor relationship ends.

Do not buy peripherals from a generic list without written compatibility. Confirm current browser, operating-system, scanner-driver, printer, label, camera, signature, network, and device requirements with HELIX and the third-party manufacturer. A compatible model number matters more than a broad product category.

For a separate look at the physical layer around the practice—not a substitute for software or clinical evaluation—see our optometry exam-room and front-desk supplies guide.

Implementation, Migration, and Acceptance Testing

The official Uprise demo page markets team-based implementation and a dedicated implementation specialist. The learning center provides role-oriented material. Those are positive inputs, not a complete statement of work.

A migration plan should define every object that moves and every object that does not:

  • patient demographics, guarantors, insurance, contacts, and consent records;
  • appointments, recalls, wait lists, and communication preferences;
  • medical histories, allergies, medications, diagnoses, exams, plans, prescriptions, and amendments;
  • images, documents, scans, attachments, diagnostic results, and structured device data;
  • charges, claims, remittances, payments, credits, refunds, statements, and open balances;
  • optical inventory, frame and lens catalogs, orders, purchase history, and retail pricing;
  • templates, favorites, macros, custom fields, fee schedules, payer rules, reports, and user roles;
  • messages, portal data, audit history, inactive patients, and retention holds; and
  • identifiers and crosswalks needed to prove that data belongs to the correct patient.

Require at least one representative rehearsal. Compare source and target counts, financial totals, samples, exceptions, attachments, and clinical continuity. Have clinical and financial owners sign the results. Preserve an independently controlled, legally appropriate source export, and do not cancel the old system until the practice can reproduce critical records and reconcile balances.

Minimum acceptance gates

The order form should make payment and go-live dependent on measurable acceptance criteria:

  1. agreed data objects converted within defined error thresholds;
  2. critical images and documents accessible from the correct patient;
  3. provider, technician, optician, front-desk, billing, finance, and administrator workflows passed;
  4. prescribing, lab, device, ordering, payer, clearinghouse, portal, and payment interfaces passed;
  5. daily and month-end reports reconciled;
  6. roles, least privilege, multi-factor controls, termination, and audit review passed;
  7. single-patient and bulk exports opened independently;
  8. downtime and manual fallback rehearsed;
  9. support contacts and severity targets verified; and
  10. defects assigned a remediation deadline, credit, delay right, or termination remedy.

Ask how a future Uprise-to-Vision(X) migration changes these gates. A “free upgrade” can still impose substantial retraining, interface, validation, and downtime costs.

Security, Privacy, HIPAA, and Business Continuity

The current HELIX privacy policy is mainly a policy for visitors to the HELIX website. It identifies VisionWeb Holdings, LLC doing business as HELIX and discusses website information. It is not a substitute for the product security exhibit, business associate agreement, service description, or customer privacy terms governing protected health information in Uprise.

Older VisionWeb pages make strong statements about HIPAA, encryption, backups, and breach history. Because those pages do not establish the current production architecture, assessment period, contractual scope, or effective product terms, this review does not repeat them as verified 2026 guarantees.

Ask for a current security package under appropriate confidentiality terms:

  • signed business associate agreement and allocation of HIPAA responsibilities;
  • product architecture and data-flow diagram;
  • hosting providers, regions, subprocessors, and cross-border transfers;
  • encryption for data in transit, at rest, and in backups, with key-management responsibility;
  • identity provider, multi-factor authentication, single sign-on, session, password, and privileged-access controls;
  • role model, audit logs, log retention, customer access, and alerting;
  • secure development, vulnerability management, penetration testing, and remediation program;
  • independent assurance reports and exact scope, period, exceptions, and bridge letter;
  • backup frequency, immutability, isolation, restore testing, recovery point objective, and recovery time objective;
  • incident detection, notification time, cooperation, forensics, and responsibility for costs;
  • customer security obligations for endpoints, browsers, networks, users, devices, and exported data; and
  • termination export, retention, deletion, backup expiry, and certification of deletion.

Then test the controls available to the practice. Terminate a test user, change a role, review an audit event, recover access, exercise a secure support workflow, and restore a non-production sample if the service permits it.

Cloud hosting does not remove the practice's obligations. The practice still controls users, endpoints, email, local networks, printed material, exported files, device integrations, patient identity, workforce training, and incident response. Obtain advice from qualified privacy, security, clinical, and legal professionals.

Availability, Support, and Downtime

HELIX currently publishes customer support at (800) 874-6601. Older official VisionWeb support pages route Uprise support through that number using menu options, but menu paths can change. Existing customers should use the support channel in their contract or authenticated application.

We did not find a public Uprise service-level agreement or a clearly branded official Uprise status page with contractual uptime history. That does not prove the service lacks internal monitoring or customer notifications. It means a buyer should obtain the service commitments before relying on cloud access for clinical and financial operations.

Request:

  • support hours, time zone, holidays, and after-hours coverage;
  • severity definitions and response, workaround, restoration, and resolution targets;
  • phone, portal, email, emergency, and escalation channels;
  • planned-maintenance notice and maintenance windows;
  • uptime calculation, exclusions, measurement source, credits, and chronic-failure exit right;
  • incident communication, root-cause reports, and status-history access;
  • support for NewCrop, Dynamic Health IT, Secure Exchange Solutions, ordering, RCM, and other dependencies;
  • named implementation and customer-success responsibilities; and
  • transition support if Uprise moves to Vision(X).

Maintain a downtime kit: read-only or exported critical schedules as legally appropriate, patient and staff communication scripts, paper or offline clinical and financial procedures, prescribing and emergency alternatives, reconciliation steps, vendor contacts, and criteria for switching back to normal operation. Test it without exposing real patient data.

Uprise Reviews, Complaints, and “Is It Legit?”

Uprise is legitimate in the narrow sense that it has an active official application, official training, official certification materials, live product documentation, and a named corporate owner. “Legit” does not answer whether it is reliable enough, supported enough, economical enough, or contractually safe enough for a specific practice.

Public review volume is too small for a dependable satisfaction conclusion. Capterra currently displays a 2.7/5 overall rating based on three reviews, while G2 displays 3.0/5 based on three reviews and explicitly says it lacks enough reviews to provide buying insight. The reviewers and dates overlap across directories, so these should not be treated as six independent recent customers.

The small samples contain both positive and negative experiences. Positive comments mention ease of use, navigation, customization, electronic records, and organization. Critical comments mention bugs, downtime, reporting, claims, support speed, integration behavior, and migration completeness. Most visible reviews date from 2017 through 2022, so they may not represent the current production version, current support organization, or every practice configuration.

Use the complaints as test cases rather than as a verdict:

  1. ask for current customers similar in specialty, size, locations, devices, payers, and modules;
  2. speak with an operational user, a provider, a biller, an administrator, and an IT or compliance owner—not only the reference selected for sales;
  3. ask each reference about the last outage, unresolved defect, month-end close, claim correction, report discrepancy, migration exception, and support escalation;
  4. demonstrate the exact reporting and claims workflows criticized in older reviews;
  5. obtain current incident, uptime, ticket, release, and escalation evidence where the vendor can share it; and
  6. contract for acceptance, service levels, data access, and exit rights rather than relying on a rating.

Directory scores can surface risks. They cannot substitute for product evidence from a representative configuration.

Contract and Exit Questions

HELIX's public Terms of Use, effective January 8, 2026, primarily govern website and linked-service use. They are not necessarily the negotiated Uprise subscription agreement, order form, service-level agreement, business associate agreement, or data-processing terms. Request every document incorporated by reference before signature.

Qualified counsel should review:

  • contracting entity, services, version, packages, locations, users, and third parties;
  • implementation scope, dependencies, customer duties, milestones, acceptance, and delay remedies;
  • subscription term, renewal, cancellation notice, price increases, minimums, and non-refundable fees;
  • support, maintenance, change control, deprecation, product lifecycle, and Vision(X) migration;
  • service levels, credits, chronic failure, force majeure, suspension, and termination rights;
  • ownership and permitted use of patient, practice, configuration, analytics, and derived data;
  • confidentiality, HIPAA, security, incident response, insurance, indemnity, and liability limits;
  • certifications, regulatory changes, prescribing, interfaces, and third-party service failures;
  • export format, completeness, timing, cost, assistance, read-only period, retention, and deletion; and
  • transition rights if the vendor changes ownership, product, hosting, or support model.

Perform a real export before signing and again during the term. Open the files outside Uprise, reconcile a sample, locate attachments, preserve identifiers and audit context, and estimate the cost to load the data elsewhere. “You own your data” is useful only when the practice can obtain usable data on time and on predictable terms.

Uprise vs Vision(X)

The current public evidence supports a simple distinction:

Topic Uprise Vision(X)
Public status Active login, training, FHIR documentation, certification material, and demo page HELIX public product page says the new PMS/EHR is not available yet
Public positioning Existing VisionWeb optometry PM/EHR Next-generation HELIX PM/EHR suite
Verified workflow evidence Learning catalog, certification disclosures, real-world testing, FHIR docs HELIX describes scheduling, PM, EHR, ordering, billing, patient recall, and managed-vision-care integration
Dependable public price Not found Not found
Published release or migration date No current end-of-life date found No current general-availability date found
Buyer action Confirm current new-customer eligibility and lifecycle Join the information path and ask for availability and migration specifics

Do not assume a demonstration branded “HELIX” is automatically Vision(X), or that an Uprise quote automatically includes Vision(X). Ask the presenter to show the product name and version inside the production-like environment and repeat them in the order form.

Who Should Shortlist Uprise?

Uprise deserves a controlled evaluation when a U.S. optometry practice:

  • wants an optometry-specific PM/EHR rather than a general medical platform;
  • values a browser-delivered product and existing Uprise training resources;
  • needs patient, scheduling, clinical, prescribing, billing, portal, and optical workflows evaluated together;
  • can validate the specific third-party services and interfaces it needs;
  • accepts quote-based pricing and a sales-led implementation; and
  • receives satisfactory written answers about Uprise lifecycle, Vision(X), security, service levels, data export, and contract exit.

Pause the purchase when the vendor cannot state which product is being sold, cannot define support dates, will not provide a complete price schedule, cannot demonstrate critical workflows with representative data, will not commit to migration and acceptance criteria, or cannot provide usable export and security evidence.

Existing Uprise customers have a different decision. They should inventory current modules and interfaces, document open issues, perform and validate exports, confirm their current contract, and request a written Uprise-to-Vision(X) roadmap. A stable installed workflow should not be disrupted merely because a successor is announced, but it should not be left without an exit plan either.

A Practical Demo and Contract Scorecard

Score each item as passed, failed, excluded, unknown, or committed in writing:

  1. Product identity: Uprise version, Vision(X) relationship, legal entity, hosting, and lifecycle.
  2. Clinical fit: representative exams, prescribing, orders, results, corrections, portal, and audit.
  3. Front desk: registration, duplicate detection, scheduling, forms, recalls, messages, and patient access.
  4. Optical: frames, lenses, contacts, inventory, ordering, pricing, returns, and reconciliation.
  5. Revenue cycle: eligibility, coding, claims, rejection, remittance, posting, statements, refunds, and close.
  6. Integrations: exact devices, labs, payers, services, directions, errors, versions, and support owners.
  7. Data: conversion scope, validation, FHIR, complete export, attachments, audit, and termination access.
  8. Security: BAA, identity, roles, logs, assurance, backups, incidents, and practice duties.
  9. Reliability: uptime, maintenance, status communications, disaster recovery, and downtime procedures.
  10. People: implementation staffing, role training, go-live coverage, support, and escalation.
  11. Economics: three-year total cost, usage triggers, third parties, increases, and exit cost.
  12. Contract: acceptance, renewal, cancellation, lifecycle, migration, liability, remedies, and deletion.

Weight the scorecard before the demo. A practice that cannot safely operate during an outage may weight availability more heavily than a practice focused on optical inventory. A buyer replacing another EHR may give migration and export twice the weight of cosmetic interface preferences.

Official Next Steps

Existing Uprise staff: begin at the official Uprise application login and use your practice's approved support process.

Training users: use the official Uprise Learning Center.

Prospective Uprise buyers: the official Uprise demo request is still live. In the first message, ask whether the offer is Uprise 3.1, Vision(X), or a lifecycle path involving both.

Prospective Vision(X) buyers: review the current HELIX Vision(X) page and note that its FAQ says the new product is not yet available.

General vendor contact: HELIX publishes a contact page and customer-support number (800) 874-6601.

Frequently Asked Questions

Is Uprise discontinued?

We found no current official end-of-sale, end-of-support, or discontinuation notice. Uprise has an active application, training center, FHIR documentation, certification materials, and demo page. However, its former primary product URL redirects into HELIX, where Vision(X) is presented as the next PMS/EHR and is not yet available. Ask HELIX to confirm Uprise's sales and support lifecycle in writing.

What is the Uprise login URL?

Practice staff should start at www.youruprise.com. It redirects into VisionWeb's authorization service. Do not bookmark a long authorization URL or use third-party login directories. Patients should use the portal instructions issued by their own eye-care practice.

Is Uprise the same as VisionWeb?

Uprise is a VisionWeb-branded optometry PM/EHR. On the current HELIX site, VisionWeb is presented as the optical-ordering platform, while Vision(X) is the forthcoming PMS/EHR. Ask which named product and version applies to every demonstration, quote, login, and integration.

Is Uprise cloud-based?

The official Uprise demo page describes Uprise as cloud-based, and the live application uses a web authentication flow. Confirm supported browsers, devices, locations, identity controls, downtime behavior, local peripherals, data residency, backups, and contractual availability for the exact quoted configuration.

How much does Uprise cost?

No dependable public 2026 subscription price was found. The current official demo page uses quote-based pricing. Request a three-year schedule covering subscription, providers, locations, modules, implementation, migration, prescribing, claims, RCM, messaging, interfaces, training, support, hardware, increases, and exit.

Is Uprise ONC certified?

HELIX's current disclosure identifies Uprise 3.1 and certification ID 15.04.04.2514.Upri.31.01.1.221213. Verify the current CHPL status and the exact production version before purchase. Certification applies to defined capabilities and is not a government endorsement or a guarantee of overall product quality.

Does Uprise have an API?

Uprise publishes SMART on FHIR documentation for read-only USCDI patient data and bulk export patterns. That does not establish a general read/write API for scheduling, inventory, claims, optical orders, accounting, or custom workflows. Validate each intended integration in writing and in a sandbox.

Is Uprise HIPAA compliant?

No software purchase makes a practice automatically HIPAA compliant. Obtain and review the current BAA, product security documents, responsibility matrix, incident terms, access controls, audit capabilities, and subcontractor details. Validate the practice's own users, endpoints, networks, devices, exports, policies, and training.

What do Uprise reviews say?

Capterra and G2 each display only three reviews, with overlapping users and mostly older dates. The small sample includes praise for usability and organization and criticism involving bugs, reporting, claims, support, downtime, and migration. Treat those themes as demonstration and reference-check tests, not as a statistically reliable verdict.

Should an existing Uprise practice wait for Vision(X)?

Do not make a migration decision from a public announcement alone. Ask for a written roadmap, support dates, feature comparison, price, data map, interface plan, training plan, parallel-operation option, acceptance tests, remedies, and rollback or exit path. Validate current Uprise exports before any change.

Research Method

This review prioritizes current first-party evidence: the Uprise application entry point, Uprise Learning Center, Uprise SMART on FHIR documentation, HELIX Uprise certification disclosure, 2024 real-world testing report, current Uprise demo page, HELIX Vision(X) page, HELIX corporate pages, and official support routes. Independent review directories were used only to identify themes and sample-size limits.

We did not treat old marketing statements, page copyright dates, directory descriptions, or search snippets as contractual promises. We did not invent a price, customer quotation, uptime percentage, breach record, release date, migration guarantee, integration, return on investment, or compliance outcome. Re-check linked sources and signed vendor documents because product and contract information can change after the fact-check date.